Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 8/20 | 0.44 |
| ▸ | CNR1 | P21554 | 6/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | GRK2 | P25098 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2317448 | 1.00 | MEN1 (0.46) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL2317950 | 1.00 | MEN1 (0.46) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL2318097 | 0.80 | MEN1 (0.53) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL13767024 | 0.75 | CPB2 (0.42) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL13767023 | 0.75 | CPB2 (0.42) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL13767025 | 0.75 | CPB2 (0.42) | MEN1HTTKMT2ASMN1; SMN2NPSR1 | |
| SCHEMBL2320009 | 0.74 | HSD11B1 (0.56) | SMN1; SMN2CNR2CNR1 | |
| SCHEMBL2360650 | 0.74 | HSD11B1 (0.56) | SMN1; SMN2CNR2CNR1 | |
| SCHEMBL2315618 | 0.74 | TDP1 (0.54) | SMN1; SMN2EPHX2 | |
| SCHEMBL14263112 | 0.74 | TDP1 (0.54) | SMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928840-B1 | 1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors | HOFFMANN LA ROCHE (CH) | 2011-08-10 | — | — | EP | disclosed |
| US-7345058-B2 | (1-Methyl-5-phenyl-1H-pyrazol-4-yl)-(trans-octahydro-isoquinolin-2-yl)methanone; 11 beta -hydroxysteroid dehydrogenase inhibitor; upregulation of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase); antidiabetic agent; type II diabetes mellitus and metabolic syndrome | HOFFMANN-LA ROCHE INC. (US) | 2008-03-18 | — | — | US | disclosed |